Baskin, E. Et Al. 2022. Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study. JOURNAL OF NEPHROLOGY , vol.35, no.4 , 1213-1222.

Baskin, E., Fidan, K., GÜLHAN, B., Gulleroglu, K., CANPOLAT, N., Yilmaz, A., ... Parmakiz, G.(2022). Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study. JOURNAL OF NEPHROLOGY , vol.35, no.4, 1213-1222.

Baskin, Esra Et Al. "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study," JOURNAL OF NEPHROLOGY , vol.35, no.4, 1213-1222, 2022

Baskin, Esra Et Al. "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study." JOURNAL OF NEPHROLOGY , vol.35, no.4, pp.1213-1222, 2022

Baskin, E. Et Al. (2022) . "Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study." JOURNAL OF NEPHROLOGY , vol.35, no.4, pp.1213-1222.

@article{article, author={Esra Baskin Et Al. }, title={Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study}, journal={JOURNAL OF NEPHROLOGY}, year=2022, pages={1213-1222} }